Search by Drug Name or NDC
NDC 43547-0295-09 FEBUXOSTAT 40 mg/1 Details
FEBUXOSTAT 40 mg/1
FEBUXOSTAT is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Solco Healthcare US LLC. The primary component is FEBUXOSTAT.
Product Information
| NDC | 43547-0295 |
|---|---|
| Product ID | 43547-295_53efc1f0-0df6-463d-bee2-a61e596d1e8a |
| Associated GPIs | |
| GCN Sequence Number | 064829 |
| GCN Sequence Number Description | febuxostat TABLET 40 MG ORAL |
| HIC3 | C7A |
| HIC3 Description | HYPERURICEMIA TX - XANTHINE OXIDASE INHIBITORS |
| GCN | 16808 |
| HICL Sequence Number | 036106 |
| HICL Sequence Number Description | FEBUXOSTAT |
| Brand/Generic | Generic |
| Proprietary Name | FEBUXOSTAT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | febuxostat |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 40 |
| Active Ingredient Units | mg/1 |
| Substance Name | FEBUXOSTAT |
| Labeler Name | Solco Healthcare US LLC |
| Pharmaceutical Class | Xanthine Oxidase Inhibitor [EPC], Xanthine Oxidase Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA206266 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43547-0295-09 (43547029509)
| NDC Package Code | 43547-295-09 |
|---|---|
| Billing NDC | 43547029509 |
| Package | 90 TABLET in 1 BOTTLE (43547-295-09) |
| Marketing Start Date | 2022-09-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |